NVAX earnings 11/09 4pm, target $175 by 11/10Let's start with, I have a love / hate relationship with NVAX. lol. It all began when I bought shares on 5/28/19, 5/30/19, 7/3/19 & 7/16/19 for 5.97, 5.71, 5.41 & 4.64 respectively. Nobody could have predicted what 2020 had in store for all of us. Like the Grateful Dead album, "What a long strange trip it's been". So it goes without saying, I just can't wrap my head around buying anymore shares of NVAX in the the double digits, let alone triple digits, the past 6 months. With that said, there's way more people out there that don't have my avoidance in investing in NVAX at these levels. As far as their NVX-CoV2373 covid-19 vaccine (credit: novavax.com), I think it's the most serious candidate out there. If the data of their Phase 2 clinical trials that started in August, are revealed before or during Q3 earnings and it's a positive result, my target is $175. The technicals show a consolidation with price spreads tightening, with higher lows the past month. So all in all, I'm bullish heading into November. Good luck and happy trading friends...
